標(biāo)題: Titlebook: Essentials in Lung Transplantation; Allan R. Glanville Book 2019 Springer International Publishing AG, part of Springer Nature 2019 Advanc [打印本頁] 作者: dilate 時(shí)間: 2025-3-21 17:10
書目名稱Essentials in Lung Transplantation影響因子(影響力)
書目名稱Essentials in Lung Transplantation影響因子(影響力)學(xué)科排名
書目名稱Essentials in Lung Transplantation網(wǎng)絡(luò)公開度
書目名稱Essentials in Lung Transplantation網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Essentials in Lung Transplantation被引頻次
書目名稱Essentials in Lung Transplantation被引頻次學(xué)科排名
書目名稱Essentials in Lung Transplantation年度引用
書目名稱Essentials in Lung Transplantation年度引用學(xué)科排名
書目名稱Essentials in Lung Transplantation讀者反饋
書目名稱Essentials in Lung Transplantation讀者反饋學(xué)科排名
作者: 胰島素 時(shí)間: 2025-3-21 23:29
Surgical Approaches: Tricks of the Trade,fortunate to have long established programs are producing excellent outcomes despite older recipients with more comorbidities and marginal donor organs including those retrieved following donation after circulatory death. The use of many functionally marginal donor lungs with resuscitative strategie作者: ethereal 時(shí)間: 2025-3-22 00:44
Donation After Brain Death Versus Donation After Circulatory Death Donors in Lung Transplantation: ssentially identical. A recent Australian audit suggested there remains a large untapped pool of DCD (but not DBD) lungs that may yet further dramatically increase lung transplant numbers. The insights gained from the last decade of DCD lung transplantation provides strategies, knowledge and techniq作者: HATCH 時(shí)間: 2025-3-22 04:44 作者: Immunoglobulin 時(shí)間: 2025-3-22 11:39 作者: 槍支 時(shí)間: 2025-3-22 14:30
Rolf M. Zinkernagel,Peter C. Doherty need to be evaluated prior to, and after transplantation..Lastly, advances in medical technologies and therapeutics have allowed patients whom in the past may not have been suitable for lung transplantation, to progress down the transplantation pathway and have similar favourable outcomes compared 作者: 槍支 時(shí)間: 2025-3-22 18:55
Contemporary topics in immunobiologyfortunate to have long established programs are producing excellent outcomes despite older recipients with more comorbidities and marginal donor organs including those retrieved following donation after circulatory death. The use of many functionally marginal donor lungs with resuscitative strategie作者: obstruct 時(shí)間: 2025-3-22 21:48 作者: 幻影 時(shí)間: 2025-3-23 02:45 作者: 休戰(zhàn) 時(shí)間: 2025-3-23 06:48
Vacuum Polarization in Nucleon Structure with severe complications and death in immunosuppressed patients. Unfortunately, the efficacy of the influenza vaccine is variable ranging from 16 to 60%..The rapid and accurate detection of CARV by means of nasopharyngeal swabs for viral PCR has had a major impact on the early diagnosis and management of these infections.作者: 外貌 時(shí)間: 2025-3-23 11:40
Loran T. Clement,Ethan M. Shevach months post transplantation. Results are encouraging for return to work and societal participation after lung transplant and highlight areas for transplant units to improve advocacy and support for patients in re-employment after transplantation.作者: 摸索 時(shí)間: 2025-3-23 17:09
Community Acquired Respiratory Viruses, with severe complications and death in immunosuppressed patients. Unfortunately, the efficacy of the influenza vaccine is variable ranging from 16 to 60%..The rapid and accurate detection of CARV by means of nasopharyngeal swabs for viral PCR has had a major impact on the early diagnosis and management of these infections.作者: 暫時(shí)過來 時(shí)間: 2025-3-23 18:23 作者: 消極詞匯 時(shí)間: 2025-3-24 00:30 作者: anticipate 時(shí)間: 2025-3-24 04:27 作者: BAN 時(shí)間: 2025-3-24 08:03
Contemporary Topics in Immunobiologyts are present that include anti-HLA donor specific antibodies (DSA), C4d staining and histological changes centered around the capillary septum. Future studies on pulmonary AMR will be facilitated by the recent publication of a consensus statement on AMR in lung transplantation.作者: 充滿裝飾 時(shí)間: 2025-3-24 12:59
HLA-DR and Renal Transplantation,plantation in this disease is extremely complex both in the timing or referral and listing for transplantation and in the peri-operative management. With careful decision making excellent long term results can be achieved.作者: myriad 時(shí)間: 2025-3-24 17:54 作者: 悲痛 時(shí)間: 2025-3-24 21:08
E. Benjamini,R. J. Scibienski,K. Thompsonxploration of the diversity and richness of this part of the respiratory microbiome in particular, especially as new tools, including next generation sequencing are beginning to answer fundamental questions. Much work remains to be done but we are in sight of the end of the beginning.作者: Transfusion 時(shí)間: 2025-3-25 03:06
Janet M. Decker,John J. Marchalonise. Over the past 2–3 decades significant improvements in long term survival and quality of life have been demonstrated. However survival after lung transplantation remains significantly shorter than survival reported in other solid organ transplants (SOT) due to chronic lung allograft dysfunction (CLAD) and infection.作者: Aqueous-Humor 時(shí)間: 2025-3-25 03:56 作者: gnarled 時(shí)間: 2025-3-25 10:54 作者: Gratuitous 時(shí)間: 2025-3-25 14:36 作者: 地牢 時(shí)間: 2025-3-25 18:48
Bronchoscopy Post Lung Transplantation,of microbiological, cytological, and histological sampling thereby enhancing the ability to make an accurate diagnosis, particularly the differentiation of rejection from infection or the presence of both. The following chapter aims to provide an insight into the use of bronchoscopy post lung transplantation.作者: 舔食 時(shí)間: 2025-3-25 21:58
Chronic Lung Allograft Dysfunction: Phenotypes and the Future, and management paradigms are discussed, as are preventative approaches. Finally, a more optimistic outlook for patients developing CLAD in coming years, based on a better understanding of pathogenesis, is outlined.作者: Hearten 時(shí)間: 2025-3-26 00:36 作者: 榨取 時(shí)間: 2025-3-26 06:06
Cellular Rejection: Is it Still Relevant?, of patients will have biopsy proven cellular rejection in the first year post transplantation. The clinical features of rejection can be subtle, particularly in the early post-transplant period and the pathology, clinical features, investigation findings, treatment and outcomes of cellular rejection will be discussed in this chapter.作者: 領(lǐng)帶 時(shí)間: 2025-3-26 11:49 作者: Nonconformist 時(shí)間: 2025-3-26 15:44 作者: 變白 時(shí)間: 2025-3-26 19:37 作者: 鞏固 時(shí)間: 2025-3-26 22:15 作者: 能夠支付 時(shí)間: 2025-3-27 03:52 作者: 多產(chǎn)魚 時(shí)間: 2025-3-27 08:09 作者: 動(dòng)脈 時(shí)間: 2025-3-27 10:47
Surgical Approaches: Tricks of the Trade,ation with improvement in quality of life and in medium to long-term survival. This success is reflected in the increasing number of lung transplants performed annually and with growth of new lung transplant centres. Unfortunately, and on the background of considerable underlying burden of communica作者: vitreous-humor 時(shí)間: 2025-3-27 13:38
Donation After Brain Death Versus Donation After Circulatory Death Donors in Lung Transplantation: al practice, the size of the donor pool of available lungs has increased dramatically in the last decade. Donation after brain death (DBD) and donation after circulatory death (DCD) lungs, both ideal and extended criteria, are now commonly utilised for transplantation in Australia. Indeed, of the 19作者: Fester 時(shí)間: 2025-3-27 19:56
Cellular Rejection: Is it Still Relevant?,ection, infection, mechanical obstruction and muscle dysfunction to name a few. Acute allograft rejection is a significant problem and up to one third of patients will have biopsy proven cellular rejection in the first year post transplantation. The clinical features of rejection can be subtle, part作者: 刺耳 時(shí)間: 2025-3-27 23:04 作者: 執(zhí)拗 時(shí)間: 2025-3-28 05:44
The Human Respiratory Microbiome: The End of the Beginning?,ria, fungi, viruses, bacteriophages and archaea. Once considered sterile, we now know that the lungs harbour a rich diversity of organisms which may vary temporally and spatially within the lungs, the so called pulmonary microbiome. Perturbations of which, occasioned by acute infections and immune s作者: 寒冷 時(shí)間: 2025-3-28 08:51
Community Acquired Respiratory Viruses,ts. CARV triggers innate and adaptive immune responses that may amplify lung allograft injury and lead to chronic lung allograft disease..Paramyxoviridea, the most important of which include respiratory syncytial, parainfluenzae and human metapneumovirus, have a propensity to cause a necrotizing bro作者: 不安 時(shí)間: 2025-3-28 11:17 作者: Toxoid-Vaccines 時(shí)間: 2025-3-28 14:48
Chronic Lung Allograft Dysfunction: Phenotypes and the Future,erans syndrome (BOS)) remains the major barrier to long-term survival after lung transplantation. CLAD affects approximately 10% of patients each year and has proven a particularly difficult problem to address, with no major improvements in survival for 3 decades. In this chapter, current diagnostic作者: ELUC 時(shí)間: 2025-3-28 19:41 作者: 誘惑 時(shí)間: 2025-3-28 23:51
Lung Transplantation for Obstructive Lung Diseases,unique challenges. Unlike the fibrotic conditions, obstructive lung diseases may have a more indolent course, and so timing of listing and transplantation becomes increasingly relevant. Given the variable natural history and progression of COPD, the use of functional assessments and use of multivari作者: 符合你規(guī)定 時(shí)間: 2025-3-29 05:54 作者: neolith 時(shí)間: 2025-3-29 07:15 作者: 水汽 時(shí)間: 2025-3-29 12:06
How to Measure Success,al rate for patients post lung transplant is 6.0 years however this rate varies according to primary diagnosis and type of transplant. For certain conditions such as emphysema the survival benefit of transplantation remains unclear. Hence the potential improvement in quality of life becomes a drivin作者: ECG769 時(shí)間: 2025-3-29 19:18 作者: pacific 時(shí)間: 2025-3-29 21:59
Rolf M. Zinkernagel,Peter C. Dohertylung transplantation have increased significantly over the last 10?years with Chronic Obstructive pulmonary disease, Idiopathic pulmonary fibrosis and Cystic Fibrosis being the main indications..Through experience and research, it is now apparent that the underlying severity of the lung condition sh作者: 吞下 時(shí)間: 2025-3-30 01:27 作者: Externalize 時(shí)間: 2025-3-30 06:15 作者: 糾纏 時(shí)間: 2025-3-30 11:20
Contemporary Topics in Immunobiologyection, infection, mechanical obstruction and muscle dysfunction to name a few. Acute allograft rejection is a significant problem and up to one third of patients will have biopsy proven cellular rejection in the first year post transplantation. The clinical features of rejection can be subtle, part作者: 遺留之物 時(shí)間: 2025-3-30 13:07
Contemporary Topics in Immunobiologyh both acute and chronic lung allograft dysfunction (CLAD). Confidence for the diagnosis of AMR increases according to how many of the diagnostic tenets are present that include anti-HLA donor specific antibodies (DSA), C4d staining and histological changes centered around the capillary septum. Futu作者: 用肘 時(shí)間: 2025-3-30 20:19
E. Benjamini,R. J. Scibienski,K. Thompsonria, fungi, viruses, bacteriophages and archaea. Once considered sterile, we now know that the lungs harbour a rich diversity of organisms which may vary temporally and spatially within the lungs, the so called pulmonary microbiome. Perturbations of which, occasioned by acute infections and immune s作者: 遵循的規(guī)范 時(shí)間: 2025-3-31 00:13
Vacuum Polarization in Nucleon Structurets. CARV triggers innate and adaptive immune responses that may amplify lung allograft injury and lead to chronic lung allograft disease..Paramyxoviridea, the most important of which include respiratory syncytial, parainfluenzae and human metapneumovirus, have a propensity to cause a necrotizing bro作者: 不來 時(shí)間: 2025-3-31 01:27
https://doi.org/10.1007/978-1-4684-2841-4le to perform bronchoscopy with bronchoalveolar lavage as well as trans-bronchial biopsy (TBBX) as part of the routine investigation of a drop in lung function greater than 20% is a vital skill for clinicians caring for lung transplant recipients. Bronchoscopy provides clinicians with a rich source
